Titanium Dioxide Nanoparticles: Prospects and Applications in Medicine.

Ziental D, Czarczynska-Goslinska B, Mlynarczyk DT, Glowacka-Sobotta A, Stanisz B, Goslinski T, Sobotta L. · 2020

Read Titanium Dioxide Nanoparticles: Prospects and Applications in Medicine. by Ziental D, Czarczynska-Goslinska B, Mlynarczyk DT, Glowacka-Sobotta A, Stanisz B, Goslinski T, Sobotta L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7075317.txt.

Introduction

Ziental and co-authors review titanium dioxide nanoparticles in medicine in the journal Nanomaterials. Titanium dioxide owes its medical interest to photoactivity. Lit by ultraviolet light in water, it makes reactive oxygen species that can kill cells. That trait built its main use: photodynamic therapy, used against maladies from psoriasis to cancer.

The particles have been studied as light-driven agents against malignant tumours and against drug-resistant bacteria. They can serve alone, built into composites, or mixed with other molecules; grafting organic compounds onto their surface creates hybrids with stronger light absorption for targeted therapy. The review gathers results from selected studies across these approaches, including pairings that join imaging with treatment. The authors present titanium dioxide as a versatile photosensitiser platform, while the field works to move its light-driven killing from the bench toward sound clinical routines.

Catalog record

CREATORZiental D, Czarczynska-Goslinska B, Mlynarczyk DT, Glowacka-Sobotta A, Stanisz B, Goslinski T, Sobotta L.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE116 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7075317

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Titanium Dioxide Nanoparticles: Prospects and Applications in Medicine By Daniel Ziental, Beata Czarczynska-Goslinska, Dariusz T Mlynarczyk, Arleta Glowacka-Sobotta, Beata Stanisz, Tomasz Goslinski, Lukasz Sobotta Published in: Nanomaterials DOI: 10.3390/nano10020387 ABSTRACT Abstract Metallic and metal oxide nanoparticles (NPs), including titanium dioxide NPs, among polymeric NPs, liposomes, micelles, quantum dots, dendrimers, or fullerenes, are becoming more and more important due to their potential use in novel medical therapies. Titanium dioxide (titanium(IV) oxide, titania, TiO2) is an inorganic compound that owes its recent rise in scientific interest to photoactivity. After the illumination in aqueous media with UV light, TiO2 produces an array of reactive oxygen species (ROS). The capability to produce ROS and thus induce cell death has found application in the photodynamic therapy (PDT) for the treatment of a wide range of maladies, from psoriasis to cancer. Titanium dioxide NPs were studied as photosensitizing agents in the treatment of malignant tumors as well as in photodynamic inactivation of antibiotic-resistant bacteria. Both TiO2 NPs themselves, as well as their composites and combinations with other molecules or biomolecules, can be successfully used as photosensitizers in PDT. Moreover, various organic compounds can be grafted on TiO2 nanoparticles, leading to hybrid materials. These nanostructures can reveal increased light absorption, allowing their further use in targeted therapy in medicine. In order to improve efficient anticancer and antimicrobial therapies, many approaches utilizing titanium dioxide were tested. Results of selected studies presenting the scope of potential uses are discussed in this review. Keywords: composites, nanoparticles, photodynamic therapy, photosensitizer, titanium dioxide 1. INTRODUCTION The intensive development of photodynamic therapy (PDT) in recent years has involved the search for new photosensitizers and specific carriers for their delivery. Among many promising approaches to be noted for photodynamic research, those in which dyes and nanoparticles (NPs) were combined led to an increase in the selectivity of the photosensitizer (PS) and/or efficacy of the therapy. At the very beginning, it should be explained that NPs constitute a particular type of particles of the size between 1 and 100 nm (with the surrounding interfacial layer) [1]. The exact definition given in ISO technical specification 80004 states that NPs are "nano-objects with all three external dimensions in the nanoscale, whose longest and shortest axes do not differ significantly". It should be noted that in the broad sense, NPs also include polymeric NPs, liposomes (multilayer), lipid micelles (unilayer), quantum dots, dendrimers, fullerenes, cubosomes, niosomes, and metallic NPs. Particular attention should be paid to the last mentioned, but exceptional category containing metallic and metal oxide NPs, for example ZnO, Au, Fe2O3, TiO2. Several studies have indicated that the application of NPs in medicine can significantly improve the effectiveness of many existing therapies. Linking drugs with NPs can enhance their selective accumulation in diseased tissues as well as penetration abilities through cell membranes. Increasing the selectivity of drugs is a great challenge for modern medicine. This goal can be achieved by research focused on therapeutic systems with increased selectivity and reduced toxicity, accompanied by higher therapeutic efficiency [2,3]. In the current review, studies focusing on titanium dioxide (titanium(IV) oxide, titania, TiO2) nanoparticles, which belong to the category of metallic NPs are reviewed. Notably, the evaluation of current TiO2 functionalization methods accompanied by the biological and medical effects of these NPs were the driving force for this work. Mass production of TiO2 began in the early twentieth century as a non-toxic substitute for a white dye for paints. Nowadays, the annual production of TiO2 exceeds four million tons per year, and this molecule has found numerous applications in everyday products (Figure 1)—as an excipient in the pharmaceutical industry, for sun cream production in the cosmetics industry, as a colorant in white plastics, and as a relatively cheap and nontoxic food pigment approved by the relevant European Union authorities for the safety of food additives [4]. Research on the possible applications of TiO2 NPs dates back to 1985 when one of the first works on the subject of photocatalytic disinfection was published [5]. Since that time, the use of TiO2 NPs in photodynamic therapy studies has been constantly increasing. It concerns TiO2 NPs’ applications as photosensitizing agents in the treatment of cancer as well as in photodynamic inactivation of antibiotic-resistant bacteria. Both TiO2 NPs themselves, as well as their composites, combinations, or hybrids with other molecules, were successfully tested as photosensitizers in photodynamic therapy. Titanium(IV) oxide NPs were applied inter alia in the synthesis of bioconjugates with cell-specific monoclonal antibodies for the treatment of malignant tumors or the preparation of black TiO2 NPs for antimicrobial therapy of antibiotic-resistant bacteria [6,7]. [Figure: Current applications and potential future use of TiO2. PDT, photodynamic therapy; PACT, antimicrobial photodynamic therapy; DSSC, dye-sensitized solar cell.] 2. PHARMACOKINETICS, BIODISTRIBUTION, AND BIOLOGICAL FATE OF TITANIUM DIOXIDE At present, relatively few publications have addressed issues related to TiO2 NPs’ pharmacokinetic characteristics. Also, some of the literature reports are contradictory or ambiguous. The pharmacokinetics of metal NPs, including TiO2, depends on many factors, including particle type, surface charge, surface coating, size, dose, and exposure route [8,9]. Titanium dioxide can generally enter the body in three ways: orally, transdermally, or by injection. Research and discussion on the bioavailability of TiO2 from the gastrointestinal tract are currently underway. There are many indications that titania does not penetrate the gastrointestinal tract at all or to a minimal extent. Animal studies have shown that 24 h after oral administration of TiO2 NPs at a dose of 100 mg per kilogram of body weight, no significant increase in NP concentration in any of the tested tissues was detected [10]. Analogous studies using even higher doses of TiO2 gave similar results confirming that orally administered TiO2 does not penetrate the gastrointestinal tract and that penetration is medically insignificant [11]. However, studies using the physiologically-based pharmacokinetic modeling technique have indicated that high concentrations of TiO2 NPs could lead to their agglomeration and thus increase their uptake by macrophages. As indicated by Bachler et al. [12], the biodistribution of TiO2 NPs can proceed via two kinetic processes utilizing their ability to penetrate through the blood vessels to the organs and by phagocytosis of NPs by the mononuclear phagocyte system. However, it should be emphasized that the pharmacokinetics of NPs after intravenous administration is different [12]. As in such case, the bioavailability of NPs is complete, their distribution in the body should be carefully considered. In a study performed by Fabian et al. [13], rats were administered intravenously with 5 mg TiO2 NPs per kg of body weight and then observed for 28 days. The animals were healthy and behaved normally throughout the test period. Histopathological study revealed that TiO2 did not accumulate at detectable levels in blood cells, plasma, brain, or lymph nodes. However, titania levels were the highest in the liver, while lower, but still elevated concentrations were observed in the spleen, lungs, and kidneys [13]. An essential observation concerning TiO2 NPs excretion by the kidneys in rats was made by Geraets et al. [14]. They noticed that TiO2 is eliminated from the body slowly, which indicates its potential tissue accumulation. This issue is not severe considering PDT because the photosensitizer is administered only once or several times during the photodynamic therapy [14]. Besides, the study performed

Read the complete text